Peanut OIT Standardization Clinic

The Division of Allergy and Immunology has a specialized Peanut Oral Immunotherapy (OIT) Standardization Clinic for standardizing peanut OIT protocols for patients with a food allergy to peanuts. A diagnosis of food allergy is determined by your child’s history of allergy symptoms, diagnostic tests and a discussion with your child’s allergist.

The Peanut OIT Standardization Clinic is coordinated by Amal H. Assa’ad, MD, a certified pediatric allergist / immunologist and Associate Director and Director of Clinical Services of Cincinnati Children’s Division of Allergy and Immunology.

The main Peanut OIT Standardization Clinic is on the Burnet Campus in Location C (Outpatient Services Building) on the fifth floor in Treatment Center 9. An initial consultation during Allergy Clinic hours will need to be scheduled to determine whether your child is a candidate for Peanut OIT Standardization Clinic. OIT for food allergens is also conducted through the Allergy Clinic. 

For this initial consultation appointment in the Allergy Clinic, call 513-636-2601. 

What is Oral Immunotherapy? (OIT)

Oral immunotherapy (OIT) is a process of building up a tolerance to a food you are allergic to. Learn how oral immunotherapy works and how to do a daily dose of OIT.

Operating Hours at the Burnet Campus

Operating hours of the Peanut OIT Standardization Clinic at Burnet Campus are every Friday afternoon except for the fifth Friday of the month. Once your child is determined to be a candidate for Peanut OIT Standardization Clinic, your Cincinnati Children’s allergy care provider will place a referral to the OIT program. Once a referral is placed, the Food Allergy Program coordinator or an Allergy / Immunology nurse will contact you with the next steps for scheduling your child for Peanut OIT Standardization Clinic appointments.

Neighborhood Locations

Peanut OIT Standardization Clinic is also offered at the Liberty Campus every Monday morning and afternoon on LA1W.

Oral Immunotherapy

Oral immunotherapy (OIT) is a process of building up tolerance to a food your child is allergic to. The goal of OIT is to decrease your child’s sensitivity to the food allergen. By slowly introducing the food allergen, it may lower the risk of life-threatening allergic reactions. The process is also known as desensitization. 

The first step in this process is to find a safe starting amount of the food for your child. During your clinic visit, the doctor will identify the right dose your child can tolerate without having allergy symptoms. Your child will then take this small amount of the food every day at home. The dose slowly increases at clinic visits. Your child will get a slightly larger amount of the food at each clinic visit, and you will give the new dose each day at home until your doctor gives you other instructions. 

Your child is a good candidate for OIT if: 

  • We can find a safe starting dose of the food allergen for your child
  • They can cooperate with eating the food every day
  • You are willing to make sure your child gets their dose of the food allergen every day;
  • You can come for clinic visits every 2 to 4 weeks for roughly 6 months or longer, depending on how the process goes with your child 

Successful Peanut Oral Immunotherapy Provides Family with Peace of Mind

Tyler Saxton.

Tyler struggled with food allergies his entire life. But after successful peanut oral immunotherapy (OIT) he is now “desensitized” to peanuts, hasn’t had an allergic reaction and is back to enjoying life — and the occasional chocolate bar.

Read the blog post.

Food Allergy Program

The Food Allergy Program is led by Dr. Amal Assa’ad, Director of Clinical Services, Division of Allergy and Immunology. The goal of the Food Allergy Program is to improve the lives of patients with food allergies and their family members by providing expert care, innovative treatments and cutting-edge research.

Read More

2017 NIAID Addendum Guidelines for Preventing Peanut Allergy

In 2015, findings from a landmark NIAID-funded clinical trial called the Learning Early About Peanut (LEAP) study showed that introducing peanut-containing foods to infants at high risk for developing peanut allergy was safe and led to an 81% relative reduction in the subsequent development of peanut allergy. Due to the strength of these results, NIAID established a coordinating committee that convened an expert panel to update the 2010 Guidelines to specifically address the prevention of peanut allergy. Amal H. Assa'ad, MD and Carina Venter, PhD, RD, contributed to the Addendum Guidelines for the Prevention of Peanut Allergy in the United States that were published in January 2017.

Read More